Health and economic impact associated with a quadrivalent HPV vaccine in Italy

Global cancer statistics

2011 • 55,498 citations

Global Cancer Statistics, 2002

2005 • 17,966 citations

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1999 • 8,737 citations

Cancer incidence, mortality and prevalence worldwide

2004 • 3,893 citations

Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions

2007 • 2,003 citations

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

2007 • 1,820 citations

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

2006 • 1,766 citations

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

2004 • 1,624 citations

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

2002 • 1,570 citations

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

2003 • 1,535 citations

Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic Abnormalities

2000 • 1,089 citations

EPIDEMIOLOGY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION

1988 • 700 citations

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

2004 • 541 citations

Model for Assessing Human Papillomavirus Vaccination Strategies

2007 • 484 citations

EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century

2003 • 478 citations

Mathematical Model for the Natural History of Human Papillomavirus Infection and Cervical Carcinogenesis

2000 • 465 citations

Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination

2008 • 445 citations

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

2007 • 443 citations

Colposcopy for the diagnosis of squamous intraepithelial lesions: A meta-analysis

1998 • 368 citations

Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial Neoplasia

2004 • 364 citations

Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs

2003 • 347 citations

Economic evaluation of human papillomavirus vaccination in the United Kingdom

2008 • 279 citations

Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US

2005 • 194 citations

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada

2007 • 181 citations

Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis

2004 • 168 citations

Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing

2007 • 144 citations

Cost-effectiveness of Human Papillomavirus Vaccination in the United States

2008 • 134 citations

Cost-effectiveness of Human Papillomavirus DNA Testing in the United Kingdom, The Netherlands, France, and Italy

2005 • 121 citations

Prevalence of human papillomavirus infection in women in Turin, Italy

2004 • 113 citations

Management of anogenital warts (condylomata acuminata).

2001 • 108 citations

The predicted effect of changes in cervical screening practice in the UK: results from a modelling study

2004 • 95 citations

Economic Evaluation of Vaccination Programmes

2002 • 95 citations

Economics notes: Discounting

1999 • 90 citations

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: a cost-effectiveness analysis

2008 • 87 citations

Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France

2008 • 85 citations

The German Cervical Cancer Screening Model: development and validation of a decision-analytic model for cervical cancer screening in Germany

2006 • 69 citations

Discounting Health Effects in Pharmacoeconomic Evaluations

2005 • 68 citations

Hysterectomy and socioeconomic position in Rome, Italy

2002 • 64 citations

Incidence, prise en charge et coût des condylomes acuminés anogénitaux chez les femmes consultant leur gynécologue en France

2007 • 64 citations

Abnormal Outcomes Following Cervical Cancer Screening: Event Duration and Health Utility Loss

2007 • 60 citations

Varicella Vaccination in Italy

2004 • 50 citations

Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland

2008 • 47 citations

The discount rate in the economic evaluation of prevention: a thought experiment

2001 • 46 citations

Incidence of Invasive Cervical Cancer and Direct Costs Associated with its Management in Italy

2009 • 32 citations

Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses

2007 • 28 citations

Treatment patterns and associated costs for genital warts in Italy

2008 • 21 citations

Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination

2007 • 20 citations

[Mortality (1995-2000) and hospital admissions (2001-2003) in the industrial area of Gela].

2006 • 18 citations

Projecting the Health and Economic Impact of a Quadrivalent HPV Vaccine using a Multi-type Transmission Dynamic Model

2006 • 4 citations